Radio and PodcastLive Radio & PodcastsScience & Medicine
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!
Oncology Times Broadcast News Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue! Cornelis van de Velde at ECCO15-ESMO34 on the largest comparis...
About This Episode
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! is an episode from Oncology Times Broadcast News. Oncology Times Broadcast News Aromatase Inhibitor...
Podcast
This episode belongs to Oncology Times Broadcast News.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 6, 2009, 00:06:57 long, audio available.
Related Episodes
Continue listening to more episodes from Oncology Times Broadcast News.
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Sep 28, 2009 - 00:07:19
For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
Sep 28, 2009 - 00:06:03
Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer
Sep 28, 2009 - 00:09:05
"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer
Sep 28, 2009 - 00:02:18
Questions About This Episode
What is Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! about?
Oncology Times Broadcast News Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue! Cornelis van de Velde at ECCO15-ESMO34 on the largest comparison of an aromatase inhibitor with tamoxifen as initial adjuvant therapy for patients with hormone receptor-positive breast cancer–analysis of results from the TEAM (Tamoxifen Exemestane Adjuvant Multinational) study reported at ECCO15-ESMO34.
Where can I listen to Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!?
You can listen to Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! from?
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! is an episode from Oncology Times Broadcast News.
How long is this episode?
This episode is 00:06:57 long.
When was this episode published?
This episode was published on Oct 6, 2009.
Can I save Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Oncology Times Broadcast News?
Yes. This page shows related episodes from Oncology Times Broadcast News when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!?
You can listen to Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue! is from Oncology Times Broadcast News.
What are the episode details?
Published Oct 6, 2009 and 00:06:57 long